AYTU Stock Summary and Trading Ideas (Aytu Biopharma | NASDAQ:AYTU)

Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.

Aytu Biopharma trades on the NASDAQ stock market under the symbol AYTU.

As of November 3, 2026, AYTU stock price declined to $1.93 with 8,625 million shares trading.

AYTU has a beta of 0.84, meaning it tends to be less sensitive to market movements. AYTU has a correlation of 0.06 to the broad based SPY ETF.

AYTU has a market cap of $20.97 million. This is considered a Sub-Micro Cap stock.

Last quarter Aytu Biopharma reported $16 million in Revenue and $.00 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.32.

In the last 3 years, AYTU traded as high as $3.45 and as low as $.95.

The top ETF exchange traded funds that AYTU belongs to (by Net Assets): VTI, VXF, DCOR, DFAC, DFSU.

AYTU has underperformed the market in the last year with a return of -15.0%, while the SPY ETF gained +11.7%. In the last 3 month period, AYTU fell short of the market, returning -13.5%, while SPY returned +1.2%. However, in the most recent 2 weeks AYTU has outperformed the stock market by returning -1.5%, while SPY returned -1.6%.

AYTU support price is $1.87 and resistance is $2.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AYTU shares will trade within this expected range on the day.